| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc | Director | Common Stock | 96,667 | $85,241 | $0.8818 | 10 Jun 2024 | Direct |
| Aeglea BioTherapeutics, Inc. | Director | Stock Option (right to buy) | 1,950,000 | 22 Jun 2023 | Direct | ||
| Dianthus Therapeutics, Inc. /DE/ | Director | Stock Option (Right to Buy) | 12,500 | 22 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 22 May 2025 | 1 | $0 | 4 | Director | 22 May 2025, 16:41 |
| XFOR | X4 Pharmaceuticals, Inc | 10 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 16:12 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 23 May 2024 | 1 | $0 | 4 | Director | 28 May 2024, 19:58 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 11 Sep 2023 | 1 | $0 | 4 | Director | 13 Sep 2023, 21:17 |
| SYRE | Aeglea BioTherapeutics, Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 30 Jun 2023, 16:30 |
| XFOR | X4 Pharmaceuticals, Inc | 13 Jun 2023 | 1 | $0 | 4 | Director | 14 Jun 2023, 16:51 |
| DNTH | Magenta Therapeutics, Inc. | 28 Jun 2022 | 1 | $0 | 4 | Director | 30 Jun 2022, 18:36 |
| SYRE | Aeglea BioTherapeutics, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 06:04 |
| XFOR | X4 Pharmaceuticals, Inc | 06 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 16:17 |
| SYRE | Aeglea BioTherapeutics, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director | 09 Jun 2021, 17:24 |
| XFOR | X4 Pharmaceuticals, Inc | 02 Jun 2021 | 1 | +$57,000 | 4 | Director | 02 Jun 2021, 17:02 |
| DNTH | Magenta Therapeutics, Inc. | 01 Jun 2021 | 1 | $0 | 4 | Director | 03 Jun 2021, 18:36 |